Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) |
Gene tagging
|
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 18551171 |
MR4 number |
|
top of page |
Parent parasite used to introduce the genetic modification |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone |
P. berghei ANKA 507cl1 (RMgm-7)
|
Other information parent line | P.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line which expresses GFP under control of a constitutive promoter (PubMed: PMID: 16242190). |
top of page |
The mutant parasite was generated by |
Name PI/Researcher | O. Silvie; K. Matuschewski |
Name Group/Department | Department of Parasitology |
Name Institute | Heidelberg University School of Medicine |
City | Heidelberg |
Country | Germany |
top of page |
Name of the mutant parasite |
RMgm number | RMgm-186 |
Principal name | slarp/mcherry |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page |
Phenotype |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Not different from wild type |
Oocyst | Not different from wild type |
Sporozoite | Sporozoites show (a weak) mCherry-fluorescence associated with the nucleus of sporozoites |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation
The mutant expresses an mCherry-tagged form of SLARP (sporozoite and liver stage asparagine-rich protein; SAP1, sporozoite asparagine-rich protein; S22).
Protein (function)
SLARP was first identified as a sporozoite-expressed gene in a suppression subtractive hybridization (SSH) screen of P. yoelii salivary gland sporozoites versus blood-stage merozoites (designated S22, sporozoite-specific gene 22).
See RMgm-172 and RMgm-185 for mutants lacking expression of SLARP/SAP1.
Phenotype
Sporozoites show (a weak) mCherry-fluorescence associated with the nucleus of sporozoites (see also 'Additional information'). No fluorescence was detected in blood stages and oocysts.
Additional information
The nucleus associated fluorescence indicates a nuclear location of SLARP/SAP1.
In an independent study IFA analysis using antibodies against SAP1 a specific sporozoite-internal staining was observed that excluded the nucleus and was distinct from circumsporozoite (CS) protein staining, suggesting a cytoplasmic location (see RMgm-172).
Other mutants
RMgm-172, RMgm-185: Mutants lacking expression of SAP1/SLARP |